OrthoApnea v *** (CFI, 2 May 2025)
| Date | 2 May 2025 |
|---|---|
| Court | CFI |
| Division | Brussels (BE) Local Division |
| Type of action | Application For Costs |
| Case number(s) | UPC_CFI_131/2025 |
| Registry reference | ACT_7974/2025 · ORD_8991/2025 · UPC_CFI_131/2025 |
| Parties | OrthoApnea S.L. and Vivisol B BV (Applicants) v. *** |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
On OrthoApnea and Vivisol’s application for EUR 92,814.62 in costs following their success in the infringement action on EP 2 331 036 against an individual defendant (UPC_CFI_131/2025), the judge rapporteur Granata (Brussels Local Division) stayed the costs proceedings until the Court of Appeal rules on the merits. The rule remains that there is no stay, but fairness and the proper administration of justice justified one here.
Question
Should costs proceedings brought after a decision on the merits be stayed where that decision is under appeal?
Decision
Neither the UPCA, the Rules of Procedure nor Directive 2004/48 require a general stay. Filing an appeal will not, as a rule, justify one (paragraph 11). However, the true successful party is the one that prevails in the last instance (paragraph 12), and Rule 295(c) and (m) as well as equity allow a stay, if need be of the court’s own motion (paragraphs 13 to 17). Here, the appeal decision was expected within about twelve months, the amount did not threaten recoverability, a reversal would give rise to a new, out-of-time costs claim, and needless decisions should be avoided (paragraph 18). The parties must inform the judge rapporteur of the outcome of the appeal (paragraph 19).
Key points for practice
- An appeal on the merits does not automatically stay costs proceedings, but the judge rapporteur may stay them, even of its own motion, for reasons of fairness and proper administration of justice.
- Practical point: the party seeking a stay should show why immediate enforcement would be inequitable, the expected length of the appeal and the risk of conflicting decisions are taken into account.
Provisions applied
- Agreement on a Unified Patent Court
- Art. 69(1) and Preamble
- Rules of Procedure
- Rules 150, 151, 156, 221 and 295(c) and (m)
- Directive 2004/48/EC
- Art. 14
- Case law cited
- Meril Life Sciences v Edwards Lifesciences, Court of Appeal, 18 January 2024, Court of Appeal, 29 July 2024 (UPC_CoA_1/2024), Court of Appeal, 18 April 2025 (UPC_CoA_166/2025), Brussels Local Division, 17 January 2025 (decision on the merits under appeal)
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Decisions in the same proceedings
Going further
Lexicon: Court fees and costs (UPC).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Parties
- claimantOrthoApnea S.L. and Vivisol B BV (Applicants)Follow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Application For Costs
- Outcome (Dhenne Avocats summary)
- La procédure de fixation des frais est suspendue jusqu'à la décision de la cour d'appel sur le fond, l'équité et la bonne administration de la justice le justifiant malgré le principe d'absence de suspension.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 2 331 036mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- OrthoApnea v *** (CFI, 25 July 2025) cited in this record
- *** v OrthoApnea (CFI, 17 January 2025) cited in this record
- Meril Life Sciences v Edwards Lifesciences (CoA, 18 January 2024) cited in this record
- AWM v Progress Maschinen & Automation (CFI, 10 February 2026) cites this decision
- Appellant*** v ORTHOAPNEA (CoA, 3 July 2025) cites this decision
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 2 331 036Device for treating night time breathing problems recorded proprietor: Personne physique (déposant individuel) | Mentioned in the analysis (role not qualified) Also mentioned in 8 other decision(s): OrthoApnea v *** (CFI, 25 July 2025) · Appellant*** v ORTHOAPNEA (CoA, 3 July 2025) · OrthoApnea v *** (CoA, 21 November 2024) · *** v OrthoApnea (CFI, 17 September 2024) · OrthoApnea v *** (CoA, 26 July 2024) · OrthoApnea (CFI, 19 July 2024) · OrthoApnea (CFI, 8 July 2024) · *** v OrthoApnea (CFI, 21 September 2023) | not recorded | not recorded | not recorded | Espacenet · European Patent Register existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically) mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.